FocusCancer

Small cell lung cancer: Time to revisit DNA-damaging chemotherapy

Science Translational Medicine  06 Jul 2016:
Vol. 8, Issue 346, pp. 346fs12
DOI: 10.1126/scitranslmed.aaf6282

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Rational use of DNA-damaging chemotherapy, with new combinations to heighten DNA replication stress, could improve outcomes in small cell lung cancer.

View Full Text

Related Content